⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10000726 | 1.00 | — | — | |
| SCHEMBL18756269 | 1.00 | — | — | |
| SCHEMBL28069239 | 1.00 | — | — | |
| SCHEMBL20047741 | 1.00 | — | — | |
| SCHEMBL13191760 | 1.00 | — | — | |
| SCHEMBL16455186 | 1.00 | — | — | |
| SCHEMBL19852927 | 0.80 | — | — | |
| SCHEMBL16392571 | 0.80 | — | — | |
| SCHEMBL9013219 | 0.80 | — | — | |
| SCHEMBL20925405 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2457918-A2 | Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes | Bristol-Myers Squibb Company (US) | 2012-05-30 | — | — | EP | disclosed |